TransCon CNP demonstrated significantly higher annualized growth velocity, the primary endpoint, compared to placebo – ...

Curogen, one of South Korea's leading biotechnology companies focused on nanotechnology-based treatments for autoimmune diseases, today announced a series of strategic appointments that strengthen its ...